PerspectiveCancer

mTORC1 Status Dictates Tumor Response to Targeted Therapeutics

See allHide authors and affiliations

Science Signaling  24 Sep 2013:
Vol. 6, Issue 294, pp. pe31
DOI: 10.1126/scisignal.2004632

Article Information

vol. 6 no. 294 pe31

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Ilana Kelsey and
  2. Brendan D. Manning*
  1. Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA, USA.
  1. *Corresponding author. E-mail: bmanning{at}hsph.harvard.edu

Altmetric

Article usage

Article usage: September 2013 to December 2019

AbstractFullPdf
Sep 2013915156529
Oct 20131237176483
Nov 20131492460
Dec 2013961028
Jan 2014852036
Feb 2014771224
Mar 2014472624
Apr 2014312221
May 201442820
Jun 2014292236
Jul 2014452528
Aug 2014531211
Sep 2014651213
Oct 201435810
Nov 201441129
Dec 201452109
Jan 2015561412
Feb 20152933
Mar 201535320
Apr 20152567
May 20153556
Jun 201529712
Jul 20151324
Aug 20151757
Sep 20152211
Oct 20151101
Nov 20152302
Dec 201510603
Jan 201655413
Feb 20162236
Mar 20166449
Apr 20161555
May 20162715
Jun 20165455
Jul 20164462
Aug 20163736
Sep 201674514
Oct 20165424
Nov 20163823
Dec 20162544
Jan 20173335
Feb 20173553
Mar 201768914
Apr 20173705
May 20174033
Jun 20171932
Jul 20171811
Aug 20173942
Sep 20172911
Oct 20172411
Nov 20172324
Dec 20171520
Jan 20182432
Feb 20183032
Mar 20184855
Apr 20184062
May 20185211
Jun 20184332
Jul 20184511
Aug 20184121
Sep 20183071
Oct 20183267
Nov 20182850
Dec 20182963
Jan 20192050
Feb 2019231010
Mar 20192175
Apr 20191061
May 20191752
Jun 20192582
Jul 20191863
Aug 20192295
Sep 20191152
Oct 20192161
Nov 20191673
Dec 2019210